BioGeometry (百奥几何) is a Beijing-based AI-native biotech building generative-AI foundation models for the life sciences — a "microscopic world model" that links protein sequence, structure and function to redesign drug discovery. Its GeoFlow model family handles de novo antibody, peptide and enzyme design, paired with an automated wet-lab platform to run a closed design-experiment-learning loop. Founded by AI4S scientist Jian Tang with Turing Award winner Yoshua Bengio as chief scientific advisor.
1
Round
1
Industry
5
Tags
Oct 28, 2026
Latest raise
Funding activity · 1 round
Oct 28, 2026
Series A
Led by China Life Capital (国寿资本)
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
